Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1969 2
1970 7
1971 2
1972 4
1973 3
1974 5
1975 3
1976 1
1977 4
1978 6
1979 3
1980 3
1981 2
1982 5
1983 3
1984 4
1986 4
1987 1
1988 4
1989 5
1990 6
1991 10
1992 1
1993 6
1994 1
1995 8
1996 16
1997 10
1998 10
1999 12
2000 24
2001 19
2002 21
2003 21
2004 42
2005 58
2006 74
2007 69
2008 94
2009 90
2010 115
2011 133
2012 153
2013 139
2014 151
2015 144
2016 180
2017 195
2018 188
2019 194
2020 233
2021 277
2022 251
2023 232
2024 186

Text availability

Article attribute

Article type

Publication date

Search Results

3,042 results

Results by year

Filters applied: . Clear all
Page 1
Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure.
Qian X, Nguyen HN, Song MM, Hadiono C, Ogden SC, Hammack C, Yao B, Hamersky GR, Jacob F, Zhong C, Yoon KJ, Jeang W, Lin L, Li Y, Thakor J, Berg DA, Zhang C, Kang E, Chickering M, Nauen D, Ho CY, Wen Z, Christian KM, Shi PY, Maher BJ, Wu H, Jin P, Tang H, Song H, Ming GL. Qian X, et al. Among authors: kang e. Cell. 2016 May 19;165(5):1238-1254. doi: 10.1016/j.cell.2016.04.032. Epub 2016 Apr 22. Cell. 2016. PMID: 27118425 Free PMC article.
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09).
Cho JH, Lim SH, An HJ, Kim KH, Park KU, Kang EJ, Choi YH, Ahn MS, Lee MH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Cho JH, et al. Among authors: kang ej. J Clin Oncol. 2020 Feb 10;38(5):488-495. doi: 10.1200/JCO.19.00931. Epub 2019 Dec 11. J Clin Oncol. 2020. PMID: 31825714 Free PMC article. Clinical Trial.
Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity.
Kim KK, Haam JH, Kim BT, Kim EM, Park JH, Rhee SY, Jeon E, Kang E, Nam GE, Koo HY, Lim JH, Jeong JE, Kim JH, Kim JW, Park JH, Hong JH, Lee SE, Min SH, Kim SJ, Kim S, Kim YH, Lee YJ, Cho YJ, Rhie YJ, Kim YH, Kang JH, Lee CB; Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO). Kim KK, et al. Among authors: kang e. J Obes Metab Syndr. 2023 Mar 30;32(1):1-24. doi: 10.7570/jomes23016. Epub 2023 Mar 22. J Obes Metab Syndr. 2023. PMID: 36945077 Free PMC article. Review.
Intrathecal Gene Therapy for Giant Axonal Neuropathy.
Bharucha-Goebel DX, Todd JJ, Saade D, Norato G, Jain M, Lehky T, Bailey RM, Chichester JA, Calcedo R, Armao D, Foley AR, Mohassel P, Tesfaye E, Carlin BP, Seremula B, Waite M, Zein WM, Huryn LA, Crawford TO, Sumner CJ, Hoke A, Heiss JD, Charnas L, Hooper JE, Bouldin TW, Kang EM, Rybin D, Gray SJ, Bönnemann CG; GAN Trial Team. Bharucha-Goebel DX, et al. Among authors: kang em. N Engl J Med. 2024 Mar 21;390(12):1092-1104. doi: 10.1056/NEJMoa2307952. N Engl J Med. 2024. PMID: 38507752
Stem cells and reproduction.
Lee Y, Kang E. Lee Y, et al. Among authors: kang e. BMB Rep. 2019 Aug;52(8):482-489. doi: 10.5483/BMBRep.2019.52.8.141. BMB Rep. 2019. PMID: 31234956 Free PMC article. Review.
Autoantibody Biomarkers in Rheumatic Diseases.
Kang EH, Ha YJ, Lee YJ. Kang EH, et al. Int J Mol Sci. 2020 Feb 18;21(4):1382. doi: 10.3390/ijms21041382. Int J Mol Sci. 2020. PMID: 32085664 Free PMC article. Review.
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Köbel M, Kang EY, Weir A, Rambau PF, Lee CH, Nelson GS, Ghatage P, Meagher NS, Riggan MJ, Alsop J, Anglesio MS, Beckmann MW, Bisinotto C, Boisen M, Boros J, Brand AH, Brooks-Wilson A, Carney ME, Coulson P, Courtney-Brooks M, Cushing-Haugen KL, Cybulski C, Deen S, El-Bahrawy MA, Elishaev E, Erber R, Fereday S; AOCS Group; Fischer A, Gayther SA, Barquin-Garcia A, Gentry-Maharaj A, Gilks CB, Gronwald H, Grube M, Harnett PR, Harris HR, Hartkopf AD, Hartmann A, Hein A, Hendley J, Hernandez BY, Huang Y, Jakubowska A, Jimenez-Linan M, Jones ME, Kennedy CJ, Kluz T, Koziak JM, Lesnock J, Lester J, Lubiński J, Longacre TA, Lycke M, Mateoiu C, McCauley BM, McGuire V, Ney B, Olawaiye A, Orsulic S, Osorio A, Paz-Ares L, Ramón Y Cajal T, Rothstein JH, Ruebner M, Schoemaker MJ, Shah M, Sharma R, Sherman ME, Shvetsov YB, Singh N, Steed H, Storr SJ, Talhouk A, Traficante N, Wang C, Whittemore AS, Widschwendter M, Wilkens LR, Winham SJ, Benitez J, Berchuck A, Bowtell DD, Candido Dos Reis FJ, Campbell I, Cook LS, DeFazio A, Doherty JA, Fasching PA, Fortner RT, García MJ, Goodman MT, Goode EL, Gronwald J, Huntsman DG, Karlan BY, Kelemen LE, Kommoss S, Le ND, Martin SG, Menon U, Modugno F, Phar… See abstract for full author list ➔ Köbel M, et al. Among authors: kang ey. J Pathol Clin Res. 2023 May;9(3):208-222. doi: 10.1002/cjp2.311. Epub 2023 Mar 22. J Pathol Clin Res. 2023. PMID: 36948887 Free PMC article.
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Köbel M, Yang RZ, Kang EY, Al-Shamma Z, Cook LS, Kinloch M, Carey MS, Hopkins L, Nelson GS, McManus KJ, Vizeacoumar FS, Vizeacoumar FJ, Freywald A, Fu Y, Reuss DE, Lee CH. Köbel M, et al. Among authors: kang ey. Gynecol Oncol. 2023 Nov;178:80-88. doi: 10.1016/j.ygyno.2023.09.016. Epub 2023 Oct 9. Gynecol Oncol. 2023. PMID: 37820398
3,042 results